drugset / Trial / NCT01715519
Vilazodone for the Treatment of Posttraumatic Stress Disorder
Phase 4
Completed
59 enrolled
Southern California Institute for Research and Education
Forest Laboratories · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether vilazodone is effective in the treatmen of Posttraumatic Stress Disorder (PTSD)and co-morbid mild or more depression.
Timeline
- Start
- 2012-10
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vilazodone | Small molecule | 40 mg | — |